Dapagliflozin on Hypotensive Heart Failure Patients After Sacubitril/Valsartan Therapy

NCT04575675 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

78

Enrollment

OTHER

Sponsor class

Conditions

Hypotension
Heart Failure

Interventions

DRUG: Dapagliflozin
DRUG: Sacubitril-Valsartan
DRUG: Beta blocker
DRUG: Mineralocorticoid Receptor Antagonist
DEVICE: Cardiac resynchronization therapy and/or implantable cardioverter defibrillator

Sponsor

Cheng-Hsin General Hospital